Pharmaceutical Preparations · NYSE
For the period ended December 31, 2020, Merck & Co., Inc. reported $48.0 billion across 7 geographies: United States ($21.03B, 43.8%), Europe, Middle East and Africa ($13.60B, 28.3%), China ($3.62B, 7.6%), Japan ($3.38B, 7.0%), and 3 smaller geographies. United States's share of the total is up from 43.4% for the period ended December 31, 2018.
Merck & Co., Inc. annual revenue by geography, as disclosed in SEC filings.
| Region | FY2018 | FY2019 | FY2020 | Share |
|---|---|---|---|---|
| United States | $18.35B | $20.52B | $21.03B | 43.8% |
| Europe, Middle East and Africa | $12.21B | $12.71B | $13.60B | 28.3% |
| China | $2.18B | $3.21B | $3.62B | 7.6% |
| Japan | $3.21B | $3.58B | $3.38B | 7.0% |
| Asia Pacific (other than China and Japan) | $2.91B | $2.94B | $2.86B | 6.0% |
| Latin America | $2.42B | $2.47B | $2.27B | 4.7% |
| Other | $1.01B | $1.41B | $1.23B | 2.6% |
| Total | $42.29B | $46.84B | $47.99B |
Parsed from the segment tables in the company’s SEC filings. Figures are as reported and are not restated or adjusted.
Data: SEC EDGAR (financials, KPIs, segments) · Yahoo Finance (price, splits, metrics, analyst estimates, news headlines). Not financial advice.